Johnson & Johnson Vision announced the U.S. launch of expanded parameters for 1-Day Acuvue Moist Brand Contact Lenses for Astigmatism, a daily disposable contact lens that offers patients Blink-Stabilized Design for clear, stable vision and Lacreon Technology that provides a cushion of moisture for long-lasting comfort.
Nearly 1 out of every 2 vision corrected patients has astigmatism in at least one eye, and full correction can provide them with improved visual quality of life. With the addition of 48% more lens parameters for patients with astigmatism, the 1-Day Acuvue Moist Brand Contact Lens family now offers coverage for nearly 96% of spherical and astigmatic eyes and the Acuvue Family of 1-Day Contact Lenses for Astigmatism now offers the largest range of parameters among daily disposable contact lenses, according to Johnson & Johnson Vision.
“With nearly half of patients requiring correction for astigmatism in at least one eye, having access to 2,260 parameters helps ensure that nearly every astigmatic contact lens patient has the opportunity to try a leading daily disposable lens with 1-Day Acuvue Moist for Astigmatism,” Giovanna E. Olivares, OD, Global Astigmatism Platform Director, Johnson & Johnson Vision Care, said in a company news release. “And for the doctor and staff, being able to fit patients who previously may not have considered contact lenses at all is one more way that practices can deliver exceptional patient care.”
The proprietary Blink-Stabilized Design found in 1-Day Acuvue Moist for Astigmatism works naturally with the eyelids, helping to keep the lens in the correct position. Lacreon Technology embeds a moisture-rich wetting agent into the lens creating a cushion of moisture that won't blink away over time. The result is reduced friction of the lens and greater end-of-day comfort.
1-Day Acuvue Moist for Astigmatism provides Class II UV protection, blocking approximately 82% of UVA and 97% of UVB rays.
Johnson & Johnson Vision will launch expanded parameters of 1-Day Acuvue Moist for Astigmatism through its operating company, Johnson & Johnson Vision Care, Inc.